Beovu® Pre-filled Syringe for Wet AMD and DME

Beovu® pre-filled syringe contains brolucizumab 6 mg for intravitreal injection. It is used for wet age-related macular degeneration and diabetic macular edema. CanadianInsulin ships from Canada to the US, offering Canadian pricing that may help if you pay without insurance.

What Beovu® Is and How It Works

Beovu® is an anti-VEGF treatment for the retina. Its active ingredient, brolucizumab, binds to VEGF-A. This reduces abnormal blood vessel growth and leakage under the macula. The goal is to help stabilize or improve retinal anatomy and maintain vision. US delivery from Canada helps patients access therapy through a licensed supply chain.

At CanadianInsulin, orders are filled by licensed Canadian pharmacies after we confirm a valid prescription with your clinic.

The pre-filled syringe is single-use and designed for intravitreal injection only. A retina specialist administers the dose in the office. Imaging such as OCT is often used to assess fluid and guide the dosing interval. Treatment intervals may be personalized after an initial loading phase.

Who Beovu® Is For

Beovu is indicated for adults with neovascular (wet) age-related macular degeneration and diabetic macular edema. If you want background on wet AMD, see our overview of Wet Age Related Macular Degeneration.

It should not be used if there is an active eye or periocular infection, or active intraocular inflammation. People with known hypersensitivity to brolucizumab or any component should avoid it. Safety in pediatric patients has not been established. If you are pregnant, planning pregnancy, or breastfeeding, discuss potential risks and benefits with your clinician. Your retina specialist will determine whether this medicine is appropriate for your specific retinal condition.

Dosage and Usage

The dose is 6 mg (0.05 mL) given as an intravitreal injection into the affected eye. Injections are performed by a qualified eye care professional under aseptic conditions. Anesthetic drops and antiseptic preparation are used according to clinic practice.

For wet AMD, treatment typically starts with three monthly injections. After the loading phase, many patients continue every 8 weeks, with some extended to every 12 weeks based on disease activity and OCT findings.

For diabetic macular edema, a longer loading phase is often used. Patients may receive monthly doses for the initial period, then move to every 8 weeks, with potential extension to 12 weeks if the retina remains controlled. Your clinician will set the schedule according to the label and your response.

Only healthcare professionals should prepare and inject this product. Do not attempt self-injection.

Strengths and Forms

Commonly supplied presentation:

• Pre-filled syringe: 6 mg/0.05 mL single-dose

Some markets also offer a single-dose vial with the same 6 mg strength. Availability may vary by supplier and timing.

Missed Dose and Timing

If an injection appointment is missed, contact the clinic to reschedule as soon as possible. The next dose timing will be adjusted by your eye care professional. Do not take extra doses to make up for a missed appointment.

Storage and Travel Basics

Store the pre-filled syringe refrigerated at 2°C to 8°C (36°F to 46°F). Keep it in the original carton to protect from light. Do not freeze. Do not shake. If you need to bring the syringe to your appointment, transport it in an insulated container as instructed by your clinic. Avoid excessive heat. Do not use if the packaging is damaged or the solution appears discolored or contains particles.

We use prompt, express, cold-chain shipping to help maintain temperature control in transit.

Benefits

Beovu treatment targets the VEGF pathway to reduce fluid and leakage in the macula. It helps stabilize retinal anatomy in wet AMD and DME. Many patients transition to a maintenance schedule every 8 to 12 weeks after the loading phase, which may reduce the number of office visits. The single-use pre-filled syringe is designed for professional use, which can streamline clinic preparation.

Your clinician monitors retinal fluid, vision, and imaging to decide whether to maintain or extend intervals. This treat-and-extend approach is common in routine practice.

Side Effects and Safety

• Eye pain or discomfort
• Conjunctival hemorrhage (small red area on the white of the eye)
• Transient increased intraocular pressure after injection
• Vitreous floaters
• Blurred vision
• Cataract progression in some patients
• Foreign body sensation or eye irritation

Serious risks include endophthalmitis, retinal detachment, intraocular inflammation, retinal vasculitis, and retinal vascular occlusion. Sudden vision decrease, severe eye pain, flashes, increasing floaters, or redness require urgent evaluation. Systemic arterial thromboembolic events have been reported with intravitreal anti-VEGF agents. Discuss your cardiovascular history with your clinician. Hypersensitivity reactions can occur.

Drug Interactions and Cautions

Systemic drug interactions are unlikely because exposure is primarily ocular. However, inform your clinician about all medicines you take, including anticoagulants and antiplatelet agents, before injections. Beovu should not be given in active ocular or periocular infection, or with active intraocular inflammation. Use caution in patients with a history of intraocular inflammation or occlusive vasculitis. After injection, your clinician may check intraocular pressure and examine the eye.

What to Expect Over Time

Expect close follow-up during the loading phase. Vision and OCT are assessed at each visit. Many patients move to an 8-week interval, and some can extend to 12 weeks if the retina remains dry and stable. If fluid recurs, the interval may be shortened. Over time, your plan balances disease control with visit burden. For more background on anti-VEGF therapy in general, you may find Lucentis Uses and education on diabetes-related eye disease in Diabetic Eye Disease helpful.

Compare With Alternatives

Other approved anti-VEGF options include Eylea® and Lucentis® Prefilled Syringe. These medicines also target VEGF to reduce retinal fluid. Product selection depends on diagnosis, imaging, response, and clinician judgment. For an overview discussion comparing two widely used agents, see Eylea Vs Lucentis.

Pricing and Access

CanadianInsulin offers Canadian pricing with US delivery from Canada. You can check the Beovu pre-filled syringe price and see how Canadian pricing compares to typical US cash rates. Many patients ask about the Beovu 6 mg/0.05 mL price Canada, Beovu prefilled syringe Canadian pricing, and Beovu syringe cost comparison Canada US. If you need to buy Beovu pre-filled syringe 6 mg or order Beovu syringe online, you can start the process on this page and upload your prescription.

We serve patients paying cash, including those seeking a Beovu prefilled syringe cash price, Beovu prefilled syringe out of pocket options, or a Beovu prefilled syringe without insurance pathway. Some people also look for a low cost Beovu 6 mg syringe or discount Beovu prefilled syringe price information. Final cost depends on supply, fulfillment, and your prescription. For current offers, visit our Promotions page. Secure checkout is used for your order.

Availability and Substitutions

Availability can vary. If Beovu is temporarily unavailable, your prescriber may recommend an on-label alternative or adjust your plan. We cannot provide restock dates. Your clinic will decide the best substitute if needed.

Patient Suitability and Cost Saving Tips

Beovu may suit adults with wet AMD or DME who can attend scheduled injections and monitoring. It is not for use during active eye infection or active intraocular inflammation. People with a history of intraocular inflammation or vascular occlusion will be evaluated carefully. Your clinician weighs benefits and risks along with your medical history.

To help manage cost, consider ordering the number of single-dose syringes your prescription allows in one shipment when appropriate. This may reduce per-unit shipping costs. Enable refill reminders so you have medicine ready for your next appointment. Keep refrigeration in mind when planning storage and travel to the clinic. For diabetes-related eye health tips, see Eye Health Diabetes.

Questions to Ask Your Clinician

• Is Beovu appropriate for my wet AMD or DME based on current imaging?
• How many loading doses will I likely need before maintenance begins?
• Will my maintenance interval be every 8 weeks or can it extend to 12 weeks?
• What warning signs after injection mean I should call your office immediately?
• How will we monitor intraocular pressure and inflammation after each dose?
• If Beovu is not available, which on-label alternative fits my case?
• How should I store and transport the pre-filled syringe to the clinic if needed?

Authoritative Sources

• Beovu Official Site
• FDA Prescribing Information
• Health Canada Drug Product Database

Begin your request for Beovu pre-filled syringe with US delivery from Canada and prompt, express, cold-chain shipping.